Article 56(1) of Regulation (EC) No 1907/2006 sets out an authorisation requirement for the placing on the market and the use of substances of very high concern listed in Annex XIV to that Regulation. The compliance with that requirement, in certain cases, constitutes a significant administrative burden for undertakings. In its Communication of 18 June 2014 ‘Regulatory Fitness and Performance Programme (REFIT): State of Play and Outlook’ [COM(2014) 368 final] the Commission announced that it was considering simplifying the authorisation process in some specific cases. Simplifying the applications for continued use of substances of very high concern in the production of legacy spare parts was identified as one of the actions in the Commission Communication of 5 March 2018 ‘Commission General Report on the operation of REACH and review of certain elements’ [COM(2018) 116 final].
Recital 1, Regulation (EU) 2021/876
In forcesince 31 May 2021